Sarepta Therapeutics (SRPT) FCF Margin (2010 - 2026)
Sarepta Therapeutics' FCF Margin was 48.98% in Q2 2026, up 11.41 percentage points from 37.56% a year earlier and up 76.99 percentage points from the prior quarter.
Sarepta Therapeutics (SRPT) FCF Margin (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, Sarepta Therapeutics' FCF Margin was 4.15% through Jun 30, 2026, up 22.34 percentage points year-over-year; for FY2025, it was -13.99%, up 4.03 percentage points from FY2024.
- FCF Margin shows a five-year change of -18.66 percentage points (FY2020 to FY2025).
- In earlier years, FCF Margin was -18.02% in FY2024 (+28.40 pp), -46.42% in FY2023 (-8.24 pp), -38.17% in FY2022 (+30.45 pp) and -68.62% in FY2021 (-73.30 pp).
- The Q2 2026 figure marks the highest quarterly FCF Margin since Q1 2020.
- Compared with a year earlier, FCF Margin has increased for five straight quarters, with an average year-over-year change of +21.60 percentage points over the last eight quarters.
- The best year-over-year quarter for FCF Margin over five years was Q4 2021 (a gain of 124.32 percentage points); the worst was Q1 2023 (a drop of 35.72 percentage points).
- Per Business Quant data, SRPT's FCF Margin in the three quarters before Q2 2026 was -28.02% (Q1 2026), 28.81% (Q4 2025) and -9.39% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 33.69% |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 25.03% |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 41.97% |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 30.51% |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 38.60% |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | - |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 35.25% |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 57.81% |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 28.96% |
| 10 | Sarepta Therapeutics | 1.79 Bn | -1.47 Bn | 192.84 Mn | 14.96% |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 14.96% |
| Jun 30, 2026 | 48.98% |
| Mar 31, 2026 | -28.02% |
| Dec 31, 2025 | 28.81% |
| Sep 30, 2025 | -9.39% |
| Jun 30, 2025 | 37.56% |
| Mar 31, 2025 | -84.19% |
| Dec 31, 2024 | 8.20% |
| Sep 30, 2024 | -23.11% |
| Jun 30, 2024 | -3.92% |
| Mar 31, 2024 | -66.40% |
| Dec 31, 2023 | -18.57% |
| Sep 30, 2023 | -43.51% |
| Jun 30, 2023 | -53.65% |
| Mar 31, 2023 | -86.34% |
| Dec 31, 2022 | -38.83% |
| Sep 30, 2022 | -31.79% |
| Jun 30, 2022 | -32.50% |
| Mar 31, 2022 | -50.62% |
| Dec 31, 2021 | -15.65% |
Sarepta Therapeutics FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=SRPT&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "SRPT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=SRPT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();